DEA TRAINING REQUIREMENTS – Effective June 27, 2023

DEA TRAINING REQUIREMENTS

Effective June 27, 2023

One-Time Training Requirement for All DEA Registered Prescribers Effective June 27, 2023; Physicians Can Receive Several of the These Credits from MSSNY CME site

New York State physicians who hold a Drug Enforcement Administration (DEA) license received a letter from the DEA about the new one-time eight-hour training requirement on the treatment and management of patients with opioid or other substance use disorders. Beginning on June 27, 2023, DEA-licensed prescribers will be required to check a box on their online DEA registration form, affirming that they have completed the new training requirement.  The deadline for satisfying this requirement is the date of a prescriber’s next scheduled DEA registration submission regardless of whether it is an initial registration or a renewal registration on or after June 27, 2023. This new training requirement stems from Congress’s passage for Medication Assisted Treatment as part of the Medication Access and Training Expansion (MATE) Act which was part of the federal Omnibus Bill at the end of December 2022.

This one-time training requirement affirmation will NOT be part of future registration.

HOW TO SATISFY TRAINING REQUIREMENT

As noted in the DEA letter, there are multiple ways to satisfy this training requirement and they include:

• Physicians that are board certified in addiction medicine or addiction psychiatry from the American Board of Medical Specialties, the American Board of Addiction Medicine, or the American Osteopathic Association.
• Physicians that graduated in good standing from a medical (allopathic or osteopathic), dental, physician assistant, or advanced practice nursing school in the United States within five years of June 27, 2023, and successfully completed a comprehensive curriculum that included at least eight hours of training on: Treating and managing patients with opioid or other substance use disorders, including the appropriate clinical use of all drugs approved by the Food and Drug Administration for the treatment of a substance use disorder; or safe pharmacological management of dental pain and screening, brief intervention, and referral for appropriate treatment of patients with or at risk of developing opioid and other substance use disorders.

• Physicians can satisfy this training by engaging in a total of eight hours of training on treatment and management of patients with opioid or other substance use disorders from medical organizations such as The American Society of Addiction Medicine (ASAM); the American Academy of Addiction Psychiatry (AAAP); the American Medical Association (AMA); the American Osteopathic Association (AOA); or the American Psychiatric Association (APA).  A complete listing can be found in the DEA Letter outlining training requirements for Medication Assistant Treatment

• Past trainings on the treatment and management of patients with opioid or other substance use disorders can count towards a physician meeting this requirement and past DATA-Waived training can also count to this requirement.

MSSNY OFFERS CME PROGRAMS TO HELP MEET NEW DEA TRAINING REQUIREMENT

The DEA has also stipulated that any organization approved or accredited by the ACCME would also qualify under this requirement.   The ACCME accredits the Medical Society of the State of New York is an accredited provider of continuing medical education and has programs that would appear can be used to help full-fill this federal requirement.  MSSNY is seeking further clarification.

MSSNY three one-hour pain management CME courses are entitled:

• Pain Management, Palliative Care and Addiction 2023 Understanding the Current Legal Landscape for Prescribing
• Pain Management, Palliative Care and Addiction 2023 When to Consider Opioids for Chronic Non-Cancer and Palliative Care
• Pain Management, Palliative Care and Addiction 2023 Patients with Opioid Use Disorder
• Additionally, MSSNY offers another program entitled “Substance Use Disorders in Veterans”

These courses are currently available at the MSSNY CME site at: https://cme.mssny.org/ and are free of charge to all MSSNY members.

Physicians in New York State that have a DEA license are required under New York Stat law to complete a 3-hour pain management, palliative care and addiction course every three years.   The current three-year cycle ends on July 1, 2023.  The MSSNY course allows a prescriber to complete this state requirement and also use the course work toward the federal requirement.

Further information on this federal requirement can also be found here:

• SAMHSA’s MATE guidance document

• Updated DEA Registration Certificate after Removal of X-Waiver
• Elimination of Patient Limits for Prescribing Buprenorphine for Treatment of Opioid Use Disorder (OUD) under the Consolidated Appropriations Act (CAA) of 2023
• DEA Diversion Guidance Document Portal
• DEA Diversion Q&A Page

If there are any questions regarding this, please contact Pat Clancy, Sr. Vice President/Managing Director, MSSNY Public Health and Education Division at [email protected].